Is the renoprotective effect of erythropoietin in chronic kidney disease a myth?

Journal of the Formosan Medical Association

Volumn 112, Issue 11, 2013, Pages 655-656

  Yeh, Pei Ying ^a   Liao, Fang Ling ^a   Lin, Shuei Liong ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; NITRIC OXIDE;

ANTIGEN ANTIBODY COMPLEX; CHRONIC KIDNEY DISEASE; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; EPITHELIUM CELL; ERYTHROPOIESIS; HUMAN; INTRACELLULAR SIGNALING; MACROPHAGE; MICROVASCULATURE; MYOFIBROBLAST; NONHUMAN; PLEIOTROPY; RENAL PROTECTION; SHORT SURVEY; TISSUE OXYGENATION;

ANIMALS; ERYTHROPOIETIN; FIBROSIS; HEMATINICS; HUMANS; KIDNEY; RECOMBINANT PROTEINS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84887024325     PISSN: None     EISSN: 09296646     Source Type: Journal    
DOI: 10.1016/j.jfma.2013.03.005     Document Type: Short Survey

References (8)

1. Chang F.C., Chou Y.H., Chen Y.T., Lin S.L. Novel insights into pericyte-myofibroblast transition and therapeutic targets in renal fibrosis. J Formos Med Assoc 2012, 111:589-598.
2. Lin S.L., Duffield J.S. Macrophages in kidney injury and repair. Acta Nephrol 2012, 26:45-57.
3. Gouva C., Nikolopoulos P., Ioannidis J.P., Siamopoulos K.C. Treating anemia early in renal failure patients slows the decline of renal function: a randomized controlled trial. Kidney Int 2004, 66:753-760.
4. Brines M., Grasso G., Fiordaliso F., Sfacteria A., Ghezzi P., Fratelli M., et al. Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor. Proc Natl Acad Sci USA 2004, 101:14907-14912.
5. Elliott S., Busse L., Swift S., McCaffery I., Rossi J., Kassner P., et al. Lack of expression and function of erythropoietin receptors in the kidney. Nephrol Dial Transplant 2012, 27:2733-2745.
6. Sautina L., Sautin Y., Beem E., Zhou Z., Schuler A., Brennan J., et al. Induction of nitric oxide by erythropoietin is mediated by the β common receptor and requires interaction with VEGF receptor 2. Blood 2010, 115:896-905.
7. Nairz M., Schroll A., Moschen A.R., Sonnweber T., Theurl M., Theurl I., et al. Erythropoietin contrastingly affects bacterial infection and experimental colitis by inhibiting nuclear factor-κB-inducible immune pathways. Immunity 2011, 34:61-74.
8. Lin S.L., Castaño A.P., Nowlin B.T., Lupher M.L., Duffield J.S. Bone marrow Ly6Chigh monocytes are selectively recruited to injured kidney and differentiate into functionally distinct populations. J Immunol 2009, 183:6733-6743.